Meribank Biotech Co., Ltd.: Clinical Trials

2 trials sponsored by Meribank Biotech Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1
Phase 11Active not recruiting 1

Follow Meribank Biotech Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
UMC119-06-05 - Chronic Obstructive Pulmonary Disease
Phase 2RecruitingMeribank Biotech Co., Ltd.902024-06-112024-07-08
Mesenchymal Stem Cells for Frailty Syndrome
umbilical cord mesenchymal stem cells - Pathologic Processes
Phase 1 / Phase 2Active not recruitingMeribank Biotech Co., Ltd.662024-06-032024-07-15

Conditions studied

Frailty (1)  ·  Pathologic Processes (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Countries

Taiwan (2)